InvestmentSQURPHARMA
SQURPHARMA Approves Factory BMRE Investment
Announcement summary
- What happened
- SQURPHARMA approved a factory BMRE investment.
- Purpose
- BMRE of the company’s factory
- Facility / project
- Factory BMRE
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Board of Directors has recommended 35% cash and 7.5% stock dividend for the year ended on June 30, 2017. The Board has also approved Tk. 202.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 04.12.2017, Time: 10:00 AM, Venue: Samson H Chowdhury Centre Dhaka Club Ltd., Ramna, Dhaka. Record Date: 08.11.2017. (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005e784
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.